BioSpace News Archive

In recent years, reports of deadly animal disease outbreaks have become more recurrent. These diseases are not only a threat to the existence of many wild species but also lead to substantial livestock losses.

The Global Virus Network (GVN), a coalition comprised of the world’s preeminent human and animal virologists from 53 Centers of Excellence and 10 Affiliates in 32 countries, announced that two of its Centers of Excellence, the Peter Doherty Institute for Infection and Immunity in Melbourne, Australia and the Rega Medical Research Institute of KU Leuven, Belgium,

Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) ( the “Company”), a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests, today announced that the Company has received a positive decision from the staff of the Listing Qualifications Department of The Nasdaq Stock Market LLC (the “Staff”),

In light of the ongoing COVID-19 pandemic and taking into account guidance and protocols issued by public health and government authorities, Precigen, Inc. announced that its 2020 Annual Meeting of Shareholders has been changed to a virtual meeting to be held on June 19, 2020, at 9:00 a.m., Eastern Time.

Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop treatments for patients with severe diseases including solid tumors, hematologic cancers and autoimmune disease, today announced that Pascal Touchon, the Company’s President and Chief Executive Officer, will participate at two upcoming virtual conferences in June.

Universal Display Corporation (Nasdaq: OLED), enabling energy-efficient displays and lighting with its UniversalPHOLED® technology and materials, will hold its 2020 Annual Meeting of Shareholders in a virtual-only format beginning at 2:00pm Eastern Time on Thursday, June 18, 2020.

Acceleron Pharma Inc. (Nasdaq:XLRN), a leading biopharmaceutical company in the discovery, development, and commercialization of TGF-beta superfamily therapeutics to treat serious and rare diseases, announced today the appointment of Christopher Hite to its Board of Directors.

Invacare Corporation announced the completion of its previously announced separate private exchange transactions in which certain holders of its 5.0% Convertible Senior Notes due 2021

Brown Gibbons Lang & Company (“BGL”) is pleased to announce the merger of Synergy Surgicalists (“Synergy”), one of the nation’s top providers of surgicalist staffing to acute care settings, with EA Health Solutions (“EA Health”), the nation’s leading provider of specialty physician on-call compensation solutions and physician staffing services.

AVITA Medical Limited ACN 058 466 523 (Company) is pleased to announce that it has received confirmation from the Foreign Investment Review Board (FIRB) that the Commonwealth has no objection in relation to AVITA Therapeutics, Inc. (Avita US) acquiring all of the issued shares of the Company under the proposed scheme of arrangement to effect a redomiciliation of the Company and its subsidiaries from Australia to the United States of America.